Eric Richman, CEO of Gain Therapeutics, came from science-minded beginnings and this was the seed for his passion for science and technology as a means of helping patients with diseases that were previously undiagnosed or unaddressed. Eric’s passion and commitment to patients is the thread that runs through everything he does.
In this episode of Conversations Life Science Leaders Aren’t Having, Eric and I dive into topics that aren’t discussed enough. There some very specific golden nuggets about the current funding crunch in biotech and pharma (around 15:30 – 23:17).
Some additional highlights of our conversation include:
– Who is Eric Richman – 1:15
– Eric’s love for science and tech – 4:08
– The golden age for the life sciences – 8:08
– Impact of Company Valuation on Patients – 15:36
– Advice when facing an investment squeeze – 19:59
– Increased Efficiency in today’s workplace – 23:49
– CEO’s Unique role in 2022 – 25:29
– What employees need most – 27:24
– Psychological safety for employees – 29:29
– Intentional approach to growth – 32:01
– What I want to be known for – 33:48
– Advice to my pre-CEO self – 35:10
To connect with Eric, reach out on LinkedIn – https://www.linkedin.com/in/eric-richman-516b79/ and learn more about his work at Gain Therapeutics – https://www.gaintherapeutics.com/